Setting specifications for drug products. According to ICH Guideline Q6A, a specification is de-fined as a list of tests, references to analytical procedures, and The Art of Setting Specifications Abstract Biopharmaceutical drug substance and drug product release and stability testing, typically performed by Quality Control, is an essential part of the overall control strategy employed by a manufacturer to provide assurance of their product’s identity, purity, quality, potency, and safety. Central to achieving this objective is the process of setting specifications, which define the attributes of tests, the methods, and the acceptance criteria that pharmaceutical products Oct 18, 2024 · The setting of pharmaceutical specifications for drug substance and drug product is part of an overall control strategy which includes control of raw materials and excipients, in-process testing, process evaluation or validation, adherence to Good Manufacturing Practices, stability testing, and testing for consistency of lots. Oct 20, 2009 · Developing specifications for global drug products requires a multi-faceted approach that begins with an understanding of the attributes of the formulation, and how to assess those attributes that are critical to the safety, efficacy and quality of the final drug In this paper we discuss the practical implications involved in setting and maintaining specifications for drugs in the pharmaceutical industry. Background In the development of new pharmaceutical products it is a great challenge to establish meaningful and reasonable specifica-tions, which are scientifically sound and appropriate for APIs (chemical and biological drug substances), excipients and drug products. This document aims to assist in the establishment of a single set of global specifications for new drug substances and new drug products. In the highly regulated and meticulously controlled pharmaceutical industry, ensuring the identity, efficacy, safety, and quality of the drug substance (DS), the drug product (DP) and the ingredients is vital. It provides guidance on the setting and justification of acceptance criteria and the selection of test procedures for new drug substances of synthetic chemical origin, and new drug products produced from them. e. These include statistical process control limits, release limits, shelf life limits and in-use limits. ICH Q6A Specifications: Test procedures and acceptance criteria for new drug substances and new drug products: Chemical substances Pharmaceutical specifications comprise a list of important quality attributes for testing, references to use for test procedures, and appropriate acceptance criteria for the tests, and they are set up to ensure that when a drug product is administered to a patient, its intended therapeutic benefits and safety can be rendered appropriately. xmg fdjq iefla tkjydkq ywtz lphap cgsvwn pzxmzi wfucn clld